Susquehanna Fundamental Investments, LLC Baxter International Inc Transaction History

Susquehanna Fundamental Investments, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$53.86 - $66.8 $22.2 Million - $27.5 Million	412,153 Added 1279.98%	444,353 $23.9 Million
Q1 2022 May 16, 2022	BUY	$76.85 - $89.45 $2.47 Million - $2.88 Million	32,200 New	32,200 $2.5 Million
Q4 2021 Feb 14, 2022	SELL	$74.57 - $87.19 $6.79 Million - $7.94 Million	-91,054 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$73.77 - $83.61 $1.84 Million - $2.08 Million	-24,875 Reduced 21.46%	91,054 $7.32 Million
Q2 2021 Aug 11, 2021	SELL	$80.5 - $88.01 $6.71 Million - $7.34 Million	-83,400 Reduced 41.84%	115,929 $9.33 Million
Q1 2021 May 17, 2021	SELL	$76.38 - $86.03 $4.11 Million - $4.63 Million	-53,795 Reduced 21.25%	199,329 $16.8 Million
Q4 2020 Feb 16, 2021	BUY	$75.39 - $82.36 $5.17 Million - $5.64 Million	68,521 Added 37.12%	253,124 $20.3 Million
Q3 2020 Nov 16, 2020	BUY	$78.33 - $90.73 $5.9 Million - $6.83 Million	75,303 Added 68.9%	184,603 $14.8 Million
Q2 2020 Aug 14, 2020	BUY	$78.66 - $94.14 $8.6 Million - $10.3 Million	109,300 New	109,300 $9.41 Million

981

446M

2.22M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $19.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.